moxisylyte has been researched along with Bronchospasm in 2 studies
Moxisylyte: An alpha-adrenergic blocking agent that is used in Raynaud's disease. It is also used locally in the eye to reverse the mydriasis caused by phenylephrine and other sympathomimetic agents. (From Martindale, The Extra Pharmacopoeia, 30th ed, p1312)
Excerpt | Relevance | Reference |
---|---|---|
"In ten patients with extrinsic bronchial asthma, allergen provoked bronchospasm was significantly inhibited by the alpha receptor blocking drug thymoxamine given intravenously." | 1.25 | Effect of alpha receptor blocking drug, thymoxamine, on allergen induced bronchoconstriction in extrinsic asthma. ( Kerr, JW; Patel, KR, 1975) |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 2 (100.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, PJ | 1 |
Patel, KR | 1 |
Kerr, JW | 1 |
2 other studies available for moxisylyte and Bronchospasm
Article | Year |
---|---|
Adrenergic receptors of normal and asthmatic airways.
Topics: Adrenergic alpha-Agonists; Albuterol; Asthma; Bronchial Spasm; Catecholamines; Dose-Response Relatio | 1984 |
Effect of alpha receptor blocking drug, thymoxamine, on allergen induced bronchoconstriction in extrinsic asthma.
Topics: Administration, Intranasal; Adolescent; Adult; Airway Resistance; Allergens; Asthma; Bronchial Spasm | 1975 |